Cargando…
From Evidence to Clinical Guidelines in Antibiotic Treatment in Acute Otitis Media in Children
Acute otitis media (AOM) in children represents a public health concern, being one of the leading causes of health care visits and antibiotic prescriptions worldwide. The overall aim of this paper is to unravel the major current insights into the antibiotic treatment of AOM in children. Our approach...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7825459/ https://www.ncbi.nlm.nih.gov/pubmed/33419114 http://dx.doi.org/10.3390/antibiotics10010052 |
_version_ | 1783640314298236928 |
---|---|
author | Spoială, Elena Lia Stanciu, Gabriela Dumitrita Bild, Veronica Ababei, Daniela Carmen Gavrilovici, Cristina |
author_facet | Spoială, Elena Lia Stanciu, Gabriela Dumitrita Bild, Veronica Ababei, Daniela Carmen Gavrilovici, Cristina |
author_sort | Spoială, Elena Lia |
collection | PubMed |
description | Acute otitis media (AOM) in children represents a public health concern, being one of the leading causes of health care visits and antibiotic prescriptions worldwide. The overall aim of this paper is to unravel the major current insights into the antibiotic treatment of AOM in children. Our approach is three-fold: 1. a preclinical evaluation of antibiotics in animal models of AOM stressing on the advantages of different species when testing for different schemes of antibiotics; 2. an overview on the new antimicrobial agents whose efficacy has been demonstrated in refractory cases of AOM in children; and 3. an analysis of the different guidelines stressing on the differences and similarities between the various schemes of antibiotic treatment. The preferred therapeutic agents remain amoxicillin and the amoxicillin-clavulanate combination for AOM caused by Streptococcus pneumoniae, whereas oral cephalosporin is preferred in AOM due to Moraxella catarrhalis and Haemophilus influenzae. As for the second and third line antimicrobial treatments, there is a wide variety of suggested antibiotic classes with variations in duration and posology. The decision to prescribe antimicrobial treatment as a first-line choice is based on the severity of the symptoms in 16 of the guidelines included in this review. |
format | Online Article Text |
id | pubmed-7825459 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-78254592021-01-24 From Evidence to Clinical Guidelines in Antibiotic Treatment in Acute Otitis Media in Children Spoială, Elena Lia Stanciu, Gabriela Dumitrita Bild, Veronica Ababei, Daniela Carmen Gavrilovici, Cristina Antibiotics (Basel) Review Acute otitis media (AOM) in children represents a public health concern, being one of the leading causes of health care visits and antibiotic prescriptions worldwide. The overall aim of this paper is to unravel the major current insights into the antibiotic treatment of AOM in children. Our approach is three-fold: 1. a preclinical evaluation of antibiotics in animal models of AOM stressing on the advantages of different species when testing for different schemes of antibiotics; 2. an overview on the new antimicrobial agents whose efficacy has been demonstrated in refractory cases of AOM in children; and 3. an analysis of the different guidelines stressing on the differences and similarities between the various schemes of antibiotic treatment. The preferred therapeutic agents remain amoxicillin and the amoxicillin-clavulanate combination for AOM caused by Streptococcus pneumoniae, whereas oral cephalosporin is preferred in AOM due to Moraxella catarrhalis and Haemophilus influenzae. As for the second and third line antimicrobial treatments, there is a wide variety of suggested antibiotic classes with variations in duration and posology. The decision to prescribe antimicrobial treatment as a first-line choice is based on the severity of the symptoms in 16 of the guidelines included in this review. MDPI 2021-01-06 /pmc/articles/PMC7825459/ /pubmed/33419114 http://dx.doi.org/10.3390/antibiotics10010052 Text en © 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Spoială, Elena Lia Stanciu, Gabriela Dumitrita Bild, Veronica Ababei, Daniela Carmen Gavrilovici, Cristina From Evidence to Clinical Guidelines in Antibiotic Treatment in Acute Otitis Media in Children |
title | From Evidence to Clinical Guidelines in Antibiotic Treatment in Acute Otitis Media in Children |
title_full | From Evidence to Clinical Guidelines in Antibiotic Treatment in Acute Otitis Media in Children |
title_fullStr | From Evidence to Clinical Guidelines in Antibiotic Treatment in Acute Otitis Media in Children |
title_full_unstemmed | From Evidence to Clinical Guidelines in Antibiotic Treatment in Acute Otitis Media in Children |
title_short | From Evidence to Clinical Guidelines in Antibiotic Treatment in Acute Otitis Media in Children |
title_sort | from evidence to clinical guidelines in antibiotic treatment in acute otitis media in children |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7825459/ https://www.ncbi.nlm.nih.gov/pubmed/33419114 http://dx.doi.org/10.3390/antibiotics10010052 |
work_keys_str_mv | AT spoialaelenalia fromevidencetoclinicalguidelinesinantibiotictreatmentinacuteotitismediainchildren AT stanciugabrieladumitrita fromevidencetoclinicalguidelinesinantibiotictreatmentinacuteotitismediainchildren AT bildveronica fromevidencetoclinicalguidelinesinantibiotictreatmentinacuteotitismediainchildren AT ababeidanielacarmen fromevidencetoclinicalguidelinesinantibiotictreatmentinacuteotitismediainchildren AT gavrilovicicristina fromevidencetoclinicalguidelinesinantibiotictreatmentinacuteotitismediainchildren |